TY - JOUR
T1 - “Semantic variant primary progressive aphasia” due to comorbidity of Lewy body disease and a previous cerebral venous infarction in the left anterior temporal lobe
T2 - A case report
AU - Kakinuma, Kazuo
AU - Narita, Wataru
AU - Baba, Toru
AU - Iizuka, Osamu
AU - Nishio, Yoshiyuki
AU - Suzuki, Kyoko
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas [No. 19H04890 ] from MEXT, Japan to KS.
Publisher Copyright:
© 2021 The Authors
PY - 2021/3
Y1 - 2021/3
N2 - Primary progressive aphasia (PPA) is a neurological syndrome characterized by progressive language impairment. Various neurodegenerative disorders cause PPA. Dementia with Lewy bodies (DLB) is one known cause of PPA, and little is known about this association. Almost all published cases of PPA associated with DLB are the logopenic variant of PPA. Here, we describe the novel case of a patient with DLB presenting clinical features of the semantic variant PPA (svPPA). A 75-year-old woman was referred to our hospital with a 2-year history of progressive anomia and amnesia. Two months before admission, she had been experiencing visual hallucinations, and at the age of 60 years, she had venous infarction in the left temporal lobe, which she recovered from without any residual symptoms. Upon admission to our hospital, she displayed anomia, impaired single-word comprehension, and surface dyslexia with preserved repetition and speech production. These symptoms met the criteria for the diagnosis of svPPA. 123I-ioflupane single-photon emission computed tomography and 123I-meta-iodobenzylguanidine myocardial scintigraphy indicated DLB. Thus, she was administered donepezil, and this dramatically improved her symptoms. We hypothesize that the combination of DLB with the previous asymptomatic venous thrombosis in the left temporal lobe may have contributed to the “svPPA” in this patient. In conclusion, we show that PPA associated with DLB could be treated with donepezil, and we suggest that donepezil should be pursued as a treatment option for PPA.
AB - Primary progressive aphasia (PPA) is a neurological syndrome characterized by progressive language impairment. Various neurodegenerative disorders cause PPA. Dementia with Lewy bodies (DLB) is one known cause of PPA, and little is known about this association. Almost all published cases of PPA associated with DLB are the logopenic variant of PPA. Here, we describe the novel case of a patient with DLB presenting clinical features of the semantic variant PPA (svPPA). A 75-year-old woman was referred to our hospital with a 2-year history of progressive anomia and amnesia. Two months before admission, she had been experiencing visual hallucinations, and at the age of 60 years, she had venous infarction in the left temporal lobe, which she recovered from without any residual symptoms. Upon admission to our hospital, she displayed anomia, impaired single-word comprehension, and surface dyslexia with preserved repetition and speech production. These symptoms met the criteria for the diagnosis of svPPA. 123I-ioflupane single-photon emission computed tomography and 123I-meta-iodobenzylguanidine myocardial scintigraphy indicated DLB. Thus, she was administered donepezil, and this dramatically improved her symptoms. We hypothesize that the combination of DLB with the previous asymptomatic venous thrombosis in the left temporal lobe may have contributed to the “svPPA” in this patient. In conclusion, we show that PPA associated with DLB could be treated with donepezil, and we suggest that donepezil should be pursued as a treatment option for PPA.
KW - Dementia with Lewy bodies
KW - Donepezil
KW - Primary progressive aphasia
KW - Semantic dementia
KW - Stroke
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85100060977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100060977&partnerID=8YFLogxK
U2 - 10.1016/j.ensci.2021.100318
DO - 10.1016/j.ensci.2021.100318
M3 - Article
AN - SCOPUS:85100060977
SN - 2405-6502
VL - 22
JO - eNeurologicalSci
JF - eNeurologicalSci
M1 - 100318
ER -